Abstract
Sudden unexpected death in epilepsy (SUDEP) is defined as the abrupt, no traumatic, witnessed or unwitnessed death, occurring in benign circumstances, in an individual with epilepsy, with or without evidence for a seizure and excluding documented status epilepticus (seizure duration ≥30 min or seizures without recovery), and in which postmortem examination does not reveal a cause of death. Although the physiopathological mechanisms that underlie SUDEP remain to be clarified, the genetic background has been described to play a role in this disorder. Pathogenic variants in genes associated with epilepsy and encoding cardiac ion channels could explain the SUDEP phenotype. To test this we use the next-generation sequencing technology to sequence a cohort of SUDEP cases and its translation into clinical and forensic fields. A panel target resequencing was used to study 14 SUDEP cases from both postmortem (2 cases) and from living patients (12 cases). Genes already associated with SUDEP and also candidate genes had been investigated. Overall, 24 rare genetic variants were identified in 13 SUDEP cases. Four cases showed rare variants with complete segregation in the SCN1A, FBN1, HCN1, SCN4A, and EFHC1 genes, and one case with a rare variant in KCNQ1 gene showed incomplete pattern of inheritance. In four cases, rare variants were detected in CACNA1A, SCN11A and SCN10A, and KCNQ1 genes, but familial segregation was not possible due to lack of DNA from relatives. Finally, in the four remaining cases, the rare variants did not segregate in the family. This study confirms the link between epilepsy, sudden death, and cardiac disease. In addition, we identified new potential candidate genes for SUDEP: FBN1, HCN1, SCN4A, EFHC1, CACNA1A, SCN11A, and SCN10A. Further confirmation in larger cohorts will be necessary especially if genetic screening for SUDEP is applied to forensic and clinical medicine. Nevertheless, this study supports the emerging concept of a genetically determined cardiocerebral channelopathy.
Similar content being viewed by others
References
Nashef L, So EL, Ryvlin P, Tomson T (2012) Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 53(2):227–233. doi:10.1111/j.1528-1167.2011.03358.x
Tolstykh GP, Cavazos JE (2013) Potential mechanisms of sudden unexpected death in epilepsy. Epilepsy Behav: E&B 26(3):410–414. doi:10.1016/j.yebeh.2012.09.017
Terra VC (2012) Sudden unexpected death in epilepsy: from the lab to the clinic setting. Epilsepy Behav 26(3):415–20
Shorvon S, Tomson T (2011) Sudden unexpected death in epilepsy. Lancet 378(9808):2028–2038. doi:10.1016/S0140-6736(11)60176-1
Tu E, Bagnall RD, Duflou J, Semsarian C (2011) Post-mortem review and genetic analysis of sudden unexpected death in epilepsy (SUDEP) cases. Brain Pathol 21(2):201–208. doi:10.1111/j.1750-3639.2010.00438.x
Glasscock E (2013) Genomic biomarkers of SUDEP in brain and heart. Epilepsy Behav: E&B. doi:10.1016/j.yebeh.2013.09.019
Partemi S, Vidal MC, Striano P, Campuzano O, Allegue C, Pezzella M, Elia M, Parisi P, Belcastro V, Casellato S, Giordano L, Mastrangelo M, Pietrafusa N, Striano S, Zara F, Bianchi A, Buti D, La Neve A, Tassinari CA, Oliva A, Brugada R (2015) Genetic and forensic implications in epilepsy and cardiac arrhythmias: a case series. Int J Legal Med 129(3):495–504. doi:10.1007/s00414-014-1063-4
Wall DP, Pivovarov R, Tong M, Jung JY, Fusaro VA, DeLuca TF, Tonellato PJ (2010) Genotator: a disease-agnostic tool for genetic annotation of disease. BMC Med Genet 3:50. doi:10.1186/1755-8794-3-50
Belinky F, Nativ N, Stelzer G, Zimmerman S, Iny Stein T, Safran M, Lancet D (2015) PathCards: multi-source consolidation of human biological pathways. Database: J Biol Database Curation. doi:10.1093/database/bav006
Marco-Sola S, Sammeth M, Guigo R, Ribeca P (2012) The GEM mapper: fast, accurate and versatile alignment by filtration. Nat Methods 9(12):1185–1188. doi:10.1038/nmeth.2221
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25(16):2078–2079. doi:10.1093/bioinformatics/btp352
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297–1303. doi:10.1101/gr.107524.110
Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA. http://evs.gs.washington.edu/EVS/. Accessed Sept 2014
Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422):56–65. doi:10.1038/nature11632
Exome aggregation consortium (ExAC) C, MA. http://exac.broadinstitute.org. Accessed April 2015
Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN (2003) Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21(6):577–581. doi:10.1002/humu.10212
Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Current protocols in human genetics/editorial board, Jonathan L Haines et al. Chapter 7: Unit 7 20. doi:10.1002/0471142905.hg0720s76
Choi Y, Sims GE, Murphy S, Miller JR, Chan AP (2012) Predicting the functional effect of amino acid substitutions and indels. PLoS ONE 7(10), e46688. doi:10.1371/journal.pone.0046688
Schwarz JM, Cooper DN, Schuelke M, Seelow D (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361–362. doi:10.1038/nmeth.2890
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med: Off J Am Coll Med Genet 17(5):405–424. doi:10.1038/gim.2015.30
Campuzano O, Allegue C, Fernández A, Iglesias A, Brugada R (2015) Determining the pathogenicity of genetic variants associated with cardiac channelopathies. Sci Rep. doi:10.1038/srep07953
Parisi P, Oliva A, Coll Vidal M, Partemi S, Campuzano O, Iglesias A, Pisani D, Pascali VL, Paolino MC, Villa MP, Zara F, Tassinari CA, Striano P, Brugada R (2013) Coexistence of epilepsy and Brugada syndrome in a family with SCN5A mutation. Epilepsy Res 105(3):415–418. doi:10.1016/j.eplepsyres.2013.02.024
de Llano CT, Campuzano O, Perez-Serra A, Mademont I, Coll M, Allegue C, Iglesias A, Partemi S, Striano P, Oliva A, Brugada R (2015) Further evidence of the association between LQT syndrome and epilepsy in a family with KCNQ1 pathogenic variant. Seizure: J Br Epilepsy Assoc 25:65–67. doi:10.1016/j.seizure.2015.01.003
Buoni S, Zannolli R, Macucci F, Ansaldi S, Grasso M, Arbustini E, Fois A (2004) The FBN1 (R2726W) mutation is not fully penetrant. Ann Hum Genet 68(Pt 6):633–638. doi:10.1046/j.1529-8817.2004.00113.x
DiFrancesco JC, DiFrancesco D (2015) Dysfunctional HCN ion channels in neurological diseases. Front Cell Neurosci 6:174. doi:10.3389/fncel.2015.00071
Nava C, Dalle C, Rastetter A, Striano P, de Kovel CG, Nabbout R, Cances C, Ville D, Brilstra EH, Gobbi G, Raffo E, Bouteiller D, Marie Y, Trouillard O, Robbiano A, Keren B, Agher D, Roze E, Lesage S, Nicolas A, Brice A, Baulac M, Vogt C, El Hajj N, Schneider E, Suls A, Weckhuysen S, Gormley P, Lehesjoki AE, De Jonghe P, Helbig I, Baulac S, Zara F, Koeleman BP, Haaf T, LeGuern E, Depienne C (2014) De novo mutations in HCN1 cause early infantile epileptic encephalopathy. Nat Genet 46(6):640–645. doi:10.1038/ng.2952
Cao L, Li X, Hong D (2015) Normokalemic periodic paralysis with involuntary movements and generalized epilepsy associated with two novel mutations in SCN4A gene. Seizure: J Br Epilepsy Assoc 24:134–136. doi:10.1016/j.seizure.2014.08.005
Suzuki T, Delgado-Escueta AV, Aguan K, Alonso ME, Shi J, Hara Y, Nishida M, Numata T, Medina MT, Takeuchi T, Morita R, Bai D, Ganesh S, Sugimoto Y, Inazawa J, Bailey JN, Ochoa A, Jara-Prado A, Rasmussen A, Ramos-Peek J, Cordova S, Rubio-Donnadieu F, Inoue Y, Osawa M, Kaneko S, Oguni H, Mori Y, Yamakawa K (2004) Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet 36(8):842–849. doi:10.1038/ng1393
Yamazaki S, Ikeno K, Abe T, Tohyama J, Adachi Y (2011) Hemiconvulsion-hemiplegia-epilepsy syndrome associated with CACNA1A S218L mutation. Pediatr Neurol 45(3):193–196. doi:10.1016/j.pediatrneurol.2011.04.010
Huang J, Han C, Estacion M, Vasylyev D, Hoeijmakers JG, Gerrits MM, Tyrrell L, Lauria G, Faber CG, Dib-Hajj SD, Merkies IS, Waxman SG (2014) Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy. Brain: J Neurol 137(Pt 6):1627–1642. doi:10.1093/brain/awu079
Verkerk AO, Remme CA, Schumacher CA, Scicluna BP, Wolswinkel R, de Jonge B, Bezzina CR, Veldkamp MW (2012) Functional Nav1.8 channels in intracardiac neurons: the link between SCN10A and cardiac electrophysiology. Circ Res 111(3):333–343. doi:10.1161/CIRCRESAHA.112.274035
Acknowledgments
This work was partly supported by “Fundació La Caixa.” We also thank the Genetic Commission of the Italian League Against Epilepsy for the collaboration.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Additional information
Antonio Oliva and Ramon Brugada are co-senior authors.
Contributors
Carlo Minetti MD, PhD, Pediatric Neurology and Neuromuscular Diseases Unit, Department of Neurosciences; Institute G. Gaslini, University of Genova, Genoa, Italy
Susanna Casellato, Department of Child Neuropsychiatry, University of Sassari, Sassari, Italy
Federico Zara PhD, Laboratory of Neurogenetics, Department of Neurosciences; Institute G. Gaslini, Genoa, Italy
Amedeo Bianchi, MD, Department of Neurology and Epilepsy Centre, San Donato Hospital, Arezzo, Italy
Angela La Neve, Titti Francavilla, MD, Department of Neurological and Psychiatric Sciences, Section of 1st Neurologic Clinic, University of Bari, Bari, Italy
Carlo Alberto Tassinari MD, Department of Neurological Sciences, University of Bologna, Bologna, Italy
Rights and permissions
About this article
Cite this article
Coll, M., Allegue, C., Partemi, S. et al. Genetic investigation of sudden unexpected death in epilepsy cohort by panel target resequencing. Int J Legal Med 130, 331–339 (2016). https://doi.org/10.1007/s00414-015-1269-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-015-1269-0